Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Spach, D. H., Callis, K. P., Paauw, D. S., Houze, Y. B., Schoenknecht, F. D., Welch, D. F., Rosen, H., & Brenner, D. J. (1993) Endocarditis caused by Rochalimae quintana in a patient infected with Human Immunodeficiency Virus, J. Clin. Microbiol, 31, 692–694.
Spach, D. H., Kanter, A. S., Daniels, N. A., Nowowiejski, D. J., Larson, A. M., Schmidt, R. A., Swaminathan, B., & Brenner, D. J. (1995) Bartonella (Rochalimaea) species as a cause of apparent “Culture-negative” endocarditis, Clin. Infect. Dis., 20, 1044–1047.
Dramcourt, M., Mainardi, J. L., Brouqui, P., Vandenesch, F., Carda, A., Lehnert, F., Etienne, J., Goldstein, F., Acar, J., & Raoult, D. (1995) Bartonella (Rochalimaea) quintana endocarditis in three homeless men, N. Engl. J. Med., 332, 419–423.
Raoult, D., Fournier, P. E., Dramcourt, M., Marrie, T. J., Etienne, J., Crosserat, I, Cacoub, P., Poinsignon, Y., Leclercq, P., & Sefton, A. M. (1996) Diagnosis of 22 new cases of Bartonella endocarditis [published erratum appears in Ann. Intern. Med. (1997) 127, 249], Ann. Intern. Med., 125, 646–652.
Hadfield, T. L., Warren, R., Kass, M., Brun, E., & Levy, C. (1993) Endocarditis caused by Rochalimaea henselae, Hum. Pathol., 24, 1140–1141.
Holmes, A. H., Greenough, T. C., Balady, G. 1, Regnery, R. L., Anderson, B. E., O’Keane, J. C., Fonger, J. D., & McCrone, E. L. (1995) Bartonella henselae endocarditis in an immunocompetent adult, Clin. Infect. Dis., 21, 1004–1007.
Daly, J. S., Worthington, M. G., Brenner, D. J., Moss, C. W, Hollis, D. G., Weyant, R. S., Steigerwalt, A. G., Weaver, R. E., Daneshvar, M. I., & O’Connor, S. P. (1993) Rochalimaea elizabethae sp. Nov. isolated from a patient with endocarditis, J. Clin. Microbiol., 31, 872–881.
Jackson, L. A., Spach, D. H., Kippen, D. A., Sugy, N. K., Regnery, R. L., Sayers, M. H., & Stamm, W. E. (1996) Seroprevalence to Bartonella quintana among patients at a community clinic in downtown Seattle, J. Infect. Dis., 173, 1023–1026.
La Scola, B., & Raoult, D. (1996) Serological cross-reactions between Bartonella quinanta, Bartonella henselae, and Coxiella burnettii, J. Clin. Microbiol., 34, 2270–2274.
Ohl, M. E., & Spach, D. H. (2000) Bartonella quintana and urban trench fever, Clin. Infect. Dis., 31, 131–135.
Maurin, M., & Raoult, D. (1993) Antimicrobial susceptibility of Rochalimae quintana, Rochalimae vinsonii and the newly recognized Rochalimae henselae, J. Antimicrobial Chemother., 32, 587–594.
Musso, D., Dramcourt, M., & Raoult, D. (1995) Lack of bactericidal effect of antibiotics except aminoglycosides on Bartonella (Rochaelimae) henselae, J. Antimicrobial Chemother., 36, 101–108.
Erbel, R., Rohmann, S., Drexler, M., Mohr-Kahaly, S., Gerharz, C. D., Iversen, S., Oelert, H., & Meyer, J. (1988) Improved diagnostic value of echocardiography in patients with infective endocarditis by transesophageal approach. A prospective study, Eur. Heart J., 9, 43–53.
Mügge, A., Daniel, W. G., Frank, G., & Lichtlen, P. R. (1987) Echocardiography in infective endocarditis: Reassessment of prognostic implications of vegetation size determined by the transthoracic and transesophageal approach, J. Am. Coll. Cardiol., 14, 631–638.
Von Reyn, C. F., Levy, B. S., Arbeit, R. D., Friedland, G., & Crumpacker, C. S. (1982) Infective endocarditis: An analysis based on strict case definitions, Ann. Intern. Med., 94, 505–518.
Durack, D. T., Lukes, A. S., Bright, D. K., & Duke Endocarditis Service (1994) New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings, Am. J. Med., 96, 200–209.
Bayer, A. S., Bolger, A. F., Taubert, K. A., Wilson, W, Steckelberg, J., Karchmer, A. W., Levison, M., Chambers, H. F, Dajani, A. S., Gewitz, M. H., Newburger, J. W., Gerber, M. A., Shulman, S. T., Pallasch, T. J, Gage, T. W., & Ferrieri, P. (1988) Diagnosis and management of infective endocarditis and its complications, Circulations, 98, 2936–2948.
Cecci, E., Parrini, I., Chinaglia, A., Pomari, F., Brusasco, G., Bobbio, R., Trinchero, R., & Brusca, A. (1997) New diagnostic criteria for infective endocarditis, a study of sensitivity and specificity, Eur. Heart J., 18, 1149–1156.
Sekeres, M. A., Abrutyn, E., Berlin, J. A., Kaye, D., Kinman, J. L., Korzeniowski, O. M., Levison, M. E., Feldman, R. S., & Strom, B. L. (1997) An assessment of the usefulness of the Duke criteria for diagnosing acute infective endocarditis, Clin. Infect. Dis., 24, 1185–1190.
Hoen, B., Beguinot, I., Rabaud, C., Jaussaud, R., Selton-Suty, C., May, T., & Canton, P. (1996) The Duke criteria for diagnosing infective endocarditis are specific: analysis of 100 patients with acute fever or fever of unknown origin, Clin. Infect. Dis., 23, 298–302.
Dodds, G. A., Sexton, D. J., Durack, D. T, Bashore, T. M., Carey, G. R., & Kisslo, J. (1996) Negative predictive value of the Duke criteria for infective endocarditis, Am. J. Cardiol., 77, 403–407.
Li, J. S., Sexton, D. J., Mick, N., Nettles, R., Fowler, V. G. Jr., Ryan, T., Bashore, T., & Corey, G. R. (2000) Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis, Clin. Infect. Dis., 30, 633–638.
Weinstein, L., & Brusch, J. L. (1996) Infective endocarditis, New York: Oxford University Press.
Locassin, F., Hoen, B., Lepert, C., Selton-Suty, C., Delahaye, F., Goulet, V E. J., & Briancon, S. (1995) Procedures associated with infective endocarditis in adults. A case control study, Eur. Heart J., 16, 1968–1974.
Strom, B. L., Abrutyn, E., Berlin, J. A., Kinman, J. L., Feldman, R. S., Stolley, P. D., Levison, M. E., Korzeniowski, O. M., & Kaye, D. (1998) Dental and cardiac risk factors for infective endocarditis: a population-based case control study, Ann. Intern. Med., 129, 761–769.
van der Meer, J. T., Thompson, J., Valkenburg, H. A., & Michel, M. F. (1992) Epidemiology of bacterial endocarditis in the Netherlands II. Antecedent procedures and use of prophylaxis, Arch. Intern. Med., 152, 1869–1873.
van der Meer, J. T., Van Wijk, W., Thompson, J., Vandenbroucke, J. P., Valkenburg, H. A., & Michel, M. F. (1992) Efficacy of antibiotic prophylaxis for prevention of native-value endocarditis, Lancet, 339, 135–139.
Durack, D. T. (1998) Antibiotics for prevention of endocarditis during dentistry. Time to scale back? Ann. Intern. Med., 129, 829–831.
Wilson, W. R., Karchmer, A. W., Dajani, A. S., Taubert, K. A., Bayer, A., Kaye, D., Bisno, A. L., Ferrieri, P., Shulman, S. T., & Durack, D. T. (1995) Antibiotic treatment of adults with infective endocarditis due to streptococci, enterococci, staphylococci, and HACEK microorganisms: American Heart Association, JAMA, 274, 1706–1713.
Bayer, A. S., Bolger, A. F., Taubert, K. A., Wilson, W., Steckelberg, J., Karchmer, A. W., Levison, M., Chambers, H. F., Dajani, A. S., Gewitz, M. H., Newburger, J. W., Gerber, M. A., Shulman, S. T., Pallasch, T. J., Gage, T. W., & Ferreri, P.: American Heart Association (1998) Diagnosis and management of infective endocarditis and its complications, Circulation, 98, 2936–2948.
Chambers, H. F., Miller, R. T., & Newman, M. D. (1988) Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: two week combination therapy, Ann. Intern. Med., 109, 619–624.
Fortún, J., Navas, E., Martinez-Beltrán, J., Pérez-Molina, Martin-Davila, P., Guerrero, A., & Moreno, S. (2001) Short-course therapy for right-side endocarditis due to Staphylococcus aureus in drug abusers: cloxacillin versus glycopeptides in combination with gentamicin, Clin. Infect. Dis., 33, 120–125.
Riberia, E., Gómez-Jimenez, Cortes, E., del Valle, O., Planes, A., Gonzalez-Alujas, T., Almirante, B., Ocaña, I., & Pahissa, A. (1996) Effectiveness of cloxacillin with and without gentamicin in short-term therapy for right-sided Staphylococcus aureus endocarditis, Ann. Intern. Med., 125, 969–974.
Olaison, L., & Schaclewitz, K. for the Swedish Society of Infectious Disease Quality Assurance Study Group (2002) Enterococcal endocarditis in Sweden, 1995–1999: Can shorter therapy with aminoglycoside be used? Clin. Infect. Dis., 34, 159–166.
Rehm, S. J. (1998) Outpatient intravenous antibiotic therapy for endocarditis, in A. D. Tice (Ed.) Infectious disease clinics of North America (pp. 879–901), Philadelphia: W.B. Saunders.
Andrews, M. M., & von Reyn, C. F. (2001) Patient selection criteria and management guidelines for outpatient parenteral antibiotic therapy for native valve infective endocarditis, Clin. Infect. Dis., 33, 203–209.
John, M. D., Hibberd, P. L., Karchmer, A. W, Sleeper, L. A., & Calderwood, S. B. (1998) Staphylococcus aureus prosthetic valve endocarditis: Optimal management and risk factors for death, Clin. Infect. Dis., 26, 1302–1309.
Bishara, J., Leibovici, L., Gartman-Isreal, D., Sagie, A., Kazakov, A., Miroshnik, E., Ashkenazi, S., & Pitlik, S. (2001) Long term outcome of infective endocarditis: the impact of early surgical intervention, Clin. Infect. Dis., 33, 1636–1643.
Homer, C., & Shulman, S. T. (1991) Clinical aspects of acute rheumatic fever, J. Rheumatol., 18, 2–13.
Veasy, L. G., Weidmeier, S. E., & Orsmond, G. S. (1987) Resurgence of acute rheumatic fever in the intermountain area of the United States, N. Engl. J. Med., 316, 421–427.
Kaplan, E. L. (1991) The resurgence of group A Streptococcal infections and their sequelae, Eur. J. Clin. Microbiol. Infect. Dis., 10, 55–57.
Ayoub, E. M. (1992) Resurgence of rheumatic fever in the United States, Post Grad. Med., 92, 133–142.
Dajani, A. S. (1992) Guidelines for the diagnosis of rheumatic fever (Jones criteria, 1992 Update), JAMA, 268, 2069–2073.
Kaplan, E. L., Johnson, D. R., & Cleary, P. P. (1989) Group A. Streptococcal serotypes isolated from patients and sibling contacts during the resurgence of rheumatic fever in the United States in the mid-1980s, J. Infect. Dis., 159, 101–103.
Manjula, B. N., & Fischetti, V A. (1980) Tropomyosin-like seven residue periodicity in three immunologically distinct Streptococcal M proteins and its implications for the antiphagocytic property of the molecule, J. Exp. Med., 151, 695–708.
Manjula, B. N., Trus, B. L., & Fischetti, V. A. (1985) Presence of two distinct regions in the coiled-coil structure of the Streptococcal PeP M 5 protein: Relationship to mammalian coiled-coil proteins and implications to its biological properties, Proc. Natl Acad. Sci. USA, 82, 1064–1068.
Bessen, D., Jones, K. E, & Fischetti, V. A. (1989) Evidence for two distinct classes of Streptococcal M proteinandtheir relationship to rheumatic fever, J. Exp. Med., 169, 269–283.
Widdowson, J. P. (1980) The M-associated protein antigens of group A streptococci, in S. E. Read and J. B. Zabriskie (eds) Streptococcal diseases and the immune response, New York: Academic Press, Inc., pp. 125–147.
Dale, J. B., & Beachey, E. H. (1986) Epitopes of Streptococcal M protein shared with cardiac myosin, J. Exp. Med., 162, 583–591.
Cunningham, M. W., & Swerlick, R. A. (1986) Polyspecificity of antistreptococcal murine monoclonal antibodies and their implications in autoimmunity, J. Exp. Med., 164, 998–1012.
Barrett, L. A., & Cunningham, M. W. (1990) A new heart cross reactive antigen in Streptococcus pyogenes is not M protein, J. Infect. Dis., 162, 875–882.
Goldstein, I., Halperin, B., & Robert, L. (1967) Immunological relationship between streptococcus A polysaccharide and the structural glycoproteins of heart value, Nature, 213, 44–47.
Sandson, J., Hamerman, D., & Janis, R. (1968) Immunologic and chemical similarities between the streptococcus and human connective tissues, Trans. Assoc. Am. Physician, 81, 249–257.
Kil, K. S., Cunningham, M. W., & Barrett, L. A. (1994) Cloning and sequence analysis of a gene encoding a 60 kilodaltonmyosincross reactive antigen of Streptococcus pyogenes reveals its homology with Class II major histocompatibility antigens, Infect. Immuno., 62, 2440–2449.
Tontsch, D., Pankuweit, S., & Maisch, B. (2000) Autoantibodies in the sera of patients with rheumatic heart diseases: characterization of myocardial antigens by two-dimensional immunoblotting and N-terminal sequence analysis, Clin. Exp. Immunol., 121, 270–274.
El-Demellawy, M., El-Ridi, R., Guirguis, N. I., Abdel Alim, M., Kotby, A., & Kotb, M. (1997) Preferential recognition of human myocardial antigens by T-lymphocytes from rheumatic heart disease patients, Infect. Immuno., 65, 2197–2205.
Ayoub, E. (1986) Association of Class II human histocompatibility leucocyte antigens with rheumatic fever, J. Clin. Invest., 77, 2019–2026.
Massharaj, B., Hammond, M. G., & Appadov, B. (1987) HLA-A B, DR and DQ antigens in black patients with severe rheumatic chronic rheumatic heart disease, Circulation, 76, 259–261.
Ozkan, M., Carin, M., Sonmez, G., Senocak, M., Ozdemir, M., & Yakut, C. (1993) HLA antigens in Turkish race with rheumatic heart disease, Circulation, 87,1974–1978.
Lue, H. C., Wu, M. H., Wang, J. K., Wu, F. F., & Wu, Y. N. (1994) Long term outcome of patients with rheumatic fever receiving benzathine penicillin G prophylaxis every three weeks versus every four weeks, J. Pediatr., 125, 812–816.
Berrios, X., del Campo, E., Guzman, B., & Bisro, A. L. (1993) Discontinuing rheumatic fever prophylaxis in selected adolescents and young adults: a prospective study, Ann. Intern. Med., 118, 401–406.
Dajani, A., Taubert, K., Ferrierci, P., Peterm, G., & Shulman, S. (1995) Treatment of acute, streptococcal pharyngitis and prevention of rheumatic fever: a statement for health professionals. Committee on rheumatic fever, endocarditis, and Kowaski Disease of the council on Cardiovascular disease in the young, American Heart Association, Pediatrics, 96, 758–764.
Saphir, O. (1941) Myocarditis: A general review with an analysis of two hundred and forty cases, Arch. Pathol, 32, 1000–1051.
Gore, I., & Saphir, O. (1947) Myocarditis: a classification of 1402 cases, Am. Heart J., 34, 827–830.
Blankenhorn, M. A., & Gall, E. A. (1956) Myocarditis and myocardosis: A clinicopathologic approach, Circulation, 13, 217–223.
Drory, Y., Turetz, Y., Hiss, Y., Lev, B., Fisman, E. Z., & Kramer, M. R. (1991) Sudden unexpected death in persons less than 40 years of age, Am. J. Cardiol., 68, 1388–1392.
McCaffrey, F. M., Braden, D. S., & Strong, W. B. (1991) Sudden cardiac death in young athletes: A review, Am. J. Dis. Child., 145, 177–183.
Phillips, M., Robinowicz, J., Higgins, J. R., Boron, K. J., Reed, T., & Virmani, R. (1986) Sudden cardiac death in Air Force recruits: a 20-year review, JAMA, 256, 2696–2699.
Lie, J.T. (1988) Myocarditis and endomyocardial biopsy in unexplained heart failure: a diagnosis in search of a disease, Ann. Intern. Med., 109, 525–528.
Aretz, H. T., Billingham, M. E., Edwards, W. D., Factor, S. M., Fallion, J. T., Fengolis, J. J. Jr., Olsen, E. G., & Schoen, F. J. (1987) Myocarditis: a histopatho-logic definition and classification, Am. J. Cardiovasc. Pathol, 1, 3–14.
Mason, J. W., O’Connell, J. B., Herskowitz, A., Rose, N. R., McManus, B. M., Billingham, M. E., & Moon, T. E. (1995) A clinical trial of immunosuppressive therapy for myocarditis, N. Engl. J. Med., 308, 12–18.
Lieberman, E. B., Hutchins, G. M., Herskowitz, A., Rose, N. R., & Baughman, K. (1991) Clinico-pathologic description of myocarditis, J.Am. Coll. Cardiol, 18, 1617–1626.
Bowles, N. E., Richardson, P. J., Olsen, E. G. J., & Archard, L. C. (1986) Detection of Coxsackie-B virus specific RNA sequences in myocardial biopsy samples from patients with myocarditis and dilated cardiomyopathy, Lancet, 1, 1120–1123.
Jin, O., Sole, M. J., Buttany, J. W., Chia, W. K., McLaughlin, P. R., Liu, P., & Liew, C. C. (1990) Detection of enterovirus RNA in myocardial biopsies from patients with myocarditis and cardiomyopathy using gene amplification by polymerase chain reaction, Circulation, 82, 8–16.
Schwaiger, A., Umlauft, F., Weyner, K., Larcher, C., Lyons, J., Muhlberger, V., Dietze, D., & Grunewald, K. (1993) Detection of enteroviral ribonucleic acid in myocardial biopsies from patients with idiopathic dilated cardiomyopathy by polymerase chain reaction, Am. Heart J., 126, 406–410.
Fujioka, S., Koide, H., Kitaura, Y., Deguchi, H., Kawamura, K., & Kirai, K. (1996) Molecular detection and differentiation of enteroviruses in endomyocar-dial biopsies and pericardial effusions from dilated cardiomyopathy and myocarditis, Am. Heart J., 131, 760–765.
Why, H. J., Meany, B. T., Richardson, P. J., Olsen, E. G., Bowles, N. E., Cunningham, L., Freeke, C. A., & Archard, L. C. (1994) Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy, Circulation, 89, 2582–2589.
Fujioka, S., Kitaura, Y., Ukimua, A., Deguchi, H., Kawamura, K., Isomura, T., Suma, H., & Shimizu, A. (2000) Escalation of viral infection in the myocardium of patients with idiopathic dilated cardiomyopathy, J. Am. Coll. Cardiol., 36, 1920–1926.
Grumbach, I. M., Heim, A., Pring-Akerblom, P., Vanhof, S., Hein, W. J., Muller, G., & Figuella, R. R. (1999) Adenovirus and enteroviruses as pathogens in myocarditis and dilated cardiomyopathy, Acta Cardiol, 54, 83–88.
Matsumoni, A., Matoba, Y., & Sasayoma, S. (1995) Dilated cardiomyopathy asso-ciated with hepatitis (virus infection), Circulation, 92, 2519–2525.
Okabe, M., Fukuda, K., Arakawa, K., & Kikuchi, M. (1997) Chronic variation of myocarditis associated with hepatitis C virus infection, Circulation, 96, 22–24.
Grumbach, I. M., Heermann, K., & Figulla, H. R. (1998) Low prevalence of hep-atitis C virus antibodies and RNA in patients with myocarditis and dilated car-diomyopathy, Cardiology, 90, 75–78.
Rodriquez, E. R., Nasim, S., Hsia, J., Sandin, R. L., Ferreira, A., Hilliard, B. A., Ross, A. M., & Garrett, C. T. (1991) Cardiac myocytes and dendritic cells harbour humanimmunodeficiencyvirus in infected patients with and without cardiac dysfunction: Detection of multiplex nested, polymerase chain reaction in individ-ually microdissected cells from right ventricular endomyocardial biopsy tissue, Am. J. Cardiol, 68, 1511–1520.
Barbaro, G., Di Lorenzo, G., Grisorio, B., & Barbarini, G. for The Gruppo Italiano per Lo Stuchio Cardiologico ei Pazienti Affectti Da AIDS (1998) Incidence of dilated cardiomyopathy and detection of HIV in myocardial cells of HIV positive patients, N. Engl. J. Med., 339, 1093–1099.
Bowles, N. E., Kearney, D. L., Ni, J., Perez-Atayde, A. R., Kline, N. W., Bricker, J. T., Ayres, N. A., Lipshultz, S. E., Shearer, N. T., & Towbin, J. A. (1999) The detection of viral genomes by polymerase chain reaction in the myocardium of pediatric patients with advanced HIV disease, J. Am. Coll. Cardiol., 34, 857–865.
Rebolledo, M. A., Krogstad, P., Chen, F., Shannon, K. M., & Klitzer, T. S. (1998) Infection of human fetal cardiac myocytes by a human immunodeficiency virus-I-derived vector, Circ. Res., 83, 738–742.
Huber, S. A. (1993) Animal models: immunological aspects, in J. E. Banatvala (ed.) Viral infections of the heart, London: Edward Arnold, pp. 82–109.
Kawai, C. (1999) From myocarditis to cardiomyopathy: mechanisms of inflam-mation and cell death: learning from the past for the future, Circulation, 99, 1091–1100.
Matsumori, A., & Kawai, C. (1982) An animal model of congestive (dilated) car-diomyopathy: Dilation and hypertrophy of the heart in the chronic state in DBA/2 mice with myocarditis caused by encephalomyocarditis virus, Circulation, 66, 355–360.
Tomioka, N., Kishimoto, C., Matsumori, A., & Kawai, C. (1986) Effects of pred-nisone on acute viral myocarditis in mice, J. Am. Coll. Cardiol., 7, 868–872.
Knowlton, K. U., & Bardorff, C. (1999) The immune system in viral myocarditis: maintaining the balance, Cir. Res., 85, 559–561.
Opavsky, M. A., Penninger, J., Aitken, K., Wen, W. H., Dawood, F., Mak, T., & Liu, P. (1999) Susceptibility to myocarditis is dependent on the response of alpha P T-lymphocytes to Coxsackie viral infection, Circ. Res., 85, 551–558.
Gebhard, J. R., Perry, C. M., Harkins, S., Lane, T., Mena, I., Arsenio, V. C., Campbell, I. L., & Whitton, J. L. (1998) Coxsackie virus B3 induced myocarditis: perform exacerbates disease but plays no detectable role in viral clearance, Am.J.Pathol, 153, 417–428.
Sanderson, J. E., Koech, D., Iha, D., & Ojiambo, H. P. (1985) T-lymphocyte sub-sets in idiopathic dilated cardiomyopathy, Am. J. Cardiol., 55, 755–758.
Carforio, A. L. P., Goldman, J. H., Baig, M. K., Haven, A. J., Dalla Libera, L., Keeling, P. J., & McKennar, W. J. (1997) Cardiac autoantibodies in dilated car-diomyopathy become undetectable with disease progression, Heart, 77, 62–67.
Pankuweit, S., Portig, I., Lottspeich, F., & Maisch, B. (1997) Autoantibodies in sera of patients with myocarditis: characterization of the corresponding proteins by iso-electric focusing and N-terminal sequence analysis, J. Mol. Cell. Cardiol., 2, 77–84.
Baig, M. K., Goldman, J. H., Caforio, A. L. P., Coonar, A. S., Keeling, P. J., & McKenna, W. J. (1998) Familial dilated cardiomyopathy: cardiac abnormalities are common in asymptomatic relative and may represent early disease, J. Am. Coll. Cardiol., 31, 195–201.
Caforio, A. L. P., Keeling, P. J., Zachara, E., Mestroni, L., Camerini, F., Mann, J. M., Bottazzo, G. F., & McKenna, W. J. (1994) Evidence from family studies for autoimmunity in dilated cardiomyopathy, Lancet, 344, 773–777.
Parrillo, J. F., Cunnion, R. E., Epstein, S. E., Parker, M. M., Suffredini, A. F., Brenner, M., Schaer, G. L., Palmeri, S. T., Cannon, R. O. 3rd, & Ailing, D. (1989) A prospective randomized controlled trial of Prednisone for dilated cardiomyopathy, N. Engl. J. Med., 321, 1061–1068.
McNamara, D. M., Starling, R. L., Dec, G. W., Torre-Amione, G., Gass, A., Janosko, K. M., Tokarczyk, T., Holubkov, R., & Feldman, A. M. (1999) Intervention in myocarditis and acute cardiomyopathy with immune globulin: resultsfrom the randomized placebo-controlled IMAC trial, Circulation, 100 (Suppl. I), 1–21 [Abstract].
Latham, R. D., Mulrow, J. P., Virmani, R., Robinowitz, M., & Moody, J. M. (1989) Recently diagnosed idiopathic cardiomyopathy: incidence of myocarditis and efficacy of prednisone therapy, Am. Heart J., 117, 876–882.
Reiss, N., el-Banayosy, A., Povisal, H., Morshuis, M., Minami, K., & Korfer, R. (1996) Management of acute fulminant myocarditis usingcirculatory support systems, Artif. Organs, 20, 964–970.
Martin, J., Sarai, K., Schindler, M., van de Loo, A., Yoshitake, M., & Beyersdorf, F. (1997) MEDOS HIA-VAD biventricular assist device for bridge to recovery in fulminant myocarditis, Ann. Thorac. Surg., 63, 1145–1146.
McCarthy, R. E. III, Boehmer, J. P., Hruban, R. R. H., Hutchins, G. M., Kasper, E. K., Hare, J. M., & Baughman, K. L. (2000) Long term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis, N. Engl. J. Med., 342, 690–695.
McCormack, J. G., Bowler, S. D., Donnelly, J. E., & Steadman, C. (1998) Successful treatment of severe cytomegalovirus infection with ganciclovir in an immunocompetent host, Clin. Infect. Dis., 26, 1007–1008.
Bagkurt, C., Caglar, K., Ceviz, N., Akyug, C., & Secmeer, G. (1999) Successful treatment of Epstein-Barr virus infection associated with myocarditis, Pediatr. Int., 41, 389–391.
Rotbert, H. A., Webster, D. A., & for the Pleconaril Treatment Registry Group (2001) Treatment of potentially life-threatening enterovirus infections with pleconaril, Clin. Infect. Dis., 32, 228–235.
Maisch, B., Hufnagel, G., Schonian, U., & Hengstengberg, C. (1995) The European Study of Epidemiology and Treatment of Cardiac Inflammatory Disease (ESETCID), Eur. Heart J., 16, 173–175.
Chua, J. C., Wilkoff, B. L., Lee, I., Juratli, N, Longworth, D. L, & Gordon, S. M. (2000) Diagnosis and management of infectionsinvolving implantable electrophysiologic cardiac devices, Ann. Intern. Med., 133, 604–608.
Vaudaux, P., Francois, P., & Lew, P. D. (1998) Role of plasma and extracellular matrix proteins, in the physiopathology of foreign body infection, Ann. Vasc. Surg., 12, 34–40.
Vandecasteele, S. J., Van Wijngaerden, E., Van Elene, J., & Peetermans, W. E. (2000) New insights in the pathogenesis of foreign body infections with coagulase negative staphylococci, Acta Clinica Belgica, 55, 148–153.
Janatova, J. (2000) Activation and control of complement, inflammation, and infection associated with the use of biomedical polymers, ASAIOJ., 46, S53–62.
Frame, R., Brodman, R. F., Furman, S., Andrews, C. A., & Gross, J. N. (1993) Surgical removal of infected transvenous pacemaker leads, Pacing Clin. Eletrophysiol, 16, 2343–2348.
Kearney, R. A., Eisen, H. J., & Wolf, J. E. (1994) Non-valvular infections of the cardiovascular system, Ann. Intern. Med., 121, 219–230.
Lai, K. K., & Fontecchio, S. A. (1998) Infectionsassociated with implantable cardioverter defibrillators placed transversely and via thoracotomies: epidemiology and infections control and management, Clin. Infect Dis., 27, 265–269.
Trappe, H. J., Pfitzner, P., Klein, H., & Werzlaff, P. (1995) Infections after car-dioverter-defribrillation implantation: observation in 335 patients over 10 years, Br. Heart J., 73,20–24.
O’Nunain, S., Perez, I., Roelke, M., Osswald, S., McGovern, B. A., Brooks, D. R., Torchiana, D. F., Vlahakes, G. J., Rushkin, J., & Garan, H. (1997) The treatment of patients with infected implantable-defibrillator systems, J. Thorac. Cardiovasc. Surg., 113, 121–129.
Lewis, A. B., Hayes, D. L., Holmes, D. R. Jr., Vlietstra, R. E., Pluth, J. R., & Osborn, M. J. (1985) Update on infections involving permanent pacemakers. Characterization and management, J. Thorac. Cardiovasc. Surg., 89, 758–763.
Molina, J. E. (1997) Undertreatment and overtreatment of patients with infected antiarrhythmic implantable devices, Ann. Thorac. Surg., 63, 504–509.
Brodman, R., Frame, R., Andrews, C., & Furman, S. (1992) Removal of infected transvenous leads requiring cardiopulmonary bypass or inflow occlusion, J. Thorac. Cardiovasc. Surg., 103, 649–654.
Klug, D., Lacroix, D., Savoye, C., Goullard, L., Grandmougin, D., Hennequin, J. L., Kacet, S., & Lekieffre, J. (1997) Systemic infection related to endocarditis on pacemaker leads: clinical presentation and management, Circulation, 95, 2098–2107.
Hurst, L. N, Evans, H. B., Windle, B., & Klein, G. J. (1986) The salvage of infected cardiac pacemaker pockets using a closed irrigation system, Pacing Clin. Electrophysiol, 9, 785–792.
Garcia-Rinaldi, R., Revuetta, J. M., Bonnington, L., & Soltero-Harrington, L. (1985) The exposed cardiac pacemaker. Treatment by subfascial pocket relocation, J. Thorac. Cardiovasc. Surg., 89, 136–141.
Parry, G., Goudevenous, J., Jameson, S., Adams, P. C., & Gold, R. G. (1991) Complications associated with retained pacemaker leads, Pacing Clin. Electrophysiol., 14, 1251–1257.
Rettig, G., Doenecke, P., Sen, S., Volkmer, I., & Bette, L. (1979) Complications with retained transvenous pacemaker electrodes, Am. Heart J., 98, 587–594.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Kluwer Academic Publishers
About this chapter
Cite this chapter
(2003). New Insights and Updates for Established Entities. In: Fong, I.W. (eds) Infections and the Cardiovascular System: New Perspectives. Emerging Infectious Diseases of the 21st Century, vol 1. Springer, Boston, MA. https://doi.org/10.1007/0-306-47926-5_1
Download citation
DOI: https://doi.org/10.1007/0-306-47926-5_1
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-47404-0
Online ISBN: 978-0-306-47926-7
eBook Packages: Springer Book Archive